Tuesday, July 12, 2022

Colaboration with Czech Association of Pharmaceutical Companies

Aleš Šima

Head of Business Development

oncomed participated in a discussion with the Ministry of Health and the Ministry of Industry and Trade of the Czech Republic on the support and future of domestic drug production.

The professional round table discussion took place with the contribution and active participation of member companies of the Czech Association of Pharmaceutical Companies that have production plants in the Czech Republic. The main partners in the round table discussion were oncomed, Teva and Zentiva.

We contributed to the program by presenting a case study of the introduction of the production of a new generic drug with a focus on the main milestones and project budget, and we also presented the possibilities of vaccine production in the Czech Republic.

Pharmaceutical production in Europe and the Czech Republic has high added value and great potential for the future. We believe that our active contributions to the discussion have contributed to the future support and expansion of the domestic pharmaceutical industry.

28. 3. 2025 | Articles Events News

Grand Opening of the Pre-Filled Syringe Production Line

We have officially launched our third production line, which focuses on the manufacturing of pre-filled syringes.
read text
13. 3. 2025 | News

Young Chemist 2025 Has Its Winners

On Friday, March 7th, the finals of the Young Chemist 2025 competition took place at our facility. The competition promotes chemistry among primary school students. Participants demonstrate both their knowledge and laboratory skills, with the best ones being awarded at regional and national finals. The competition is supported by industry experts, companies, and the Association of the Chemical Industry, aiming to bridge the gap between education and real-world practice.
read text
13. 3. 2025 | News

We Attended WADC in London

From March 3rd to 5th, we participated in the 15th World ADC conference in London as part of the Proveo group, together with Oncotec and the companies Cerbios and AGC.
read text